(8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum

C55H67F3N12O11Pt2-2 — CID 159049736

IUPAC(8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum
SMILESCC(C)([NH-])C(=O)N[C@H](COCc1ccccc1)C(=O)O.CN1C(=O)N2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)[NH-])C[C@@]2(Cc2ccccn2)C1=O.O=C1N(CC(F)(F)F)C(=O)[C@]2(Cc3ccccn3)CNCCN12.[Pt].[Pt]
InChIInChI=1S/C27H33N6O5.C14H15F3N4O2.C14H19N2O4.2Pt/c1-26(2,28)23(35)30-21(17-38-16-19-9-5-4-6-10-19)22(34)32-13-14-33-25(37)31(3)24(36)27(33,18-32)15-20-11-7-8-12-29-20;15-14(16,17)9-20-11(22)13(7-10-3-1-2-4-19-10)8-18-5-6-21(13)12(20)23;1-14(2,15)13(19)16-11(12(17)18)9-20-8-10-6-4-3-5-7-10;;/h4-12,21,28H,13-18H2,1-3H3,(H,30,35);1-4,18H,5-9H2;3-7,11,15H,8-9H2,1-2H3,(H,16,19)(H,17,18);;/q-1;;-1;;/t21-,27+;13-;11-;;/m101../s1
InChIKeyPWKOLNXFTPHUJK-UNJYUEBCSA-N
MW1519.36 g/mol
LogP4.02
Rot. Bonds19

About (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum

(8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum (PubChem CID 159049736) has the molecular formula C55H67F3N12O11Pt2-2 and a molecular weight of 1519.36 g/mol. Its IUPAC name is (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum.

Molecular Properties

Compound Name(8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum
PubChem CID159049736
Molecular FormulaC55H67F3N12O11Pt2-2
Molecular Weight1519.36 g/mol
Exact Mass1518.43
IUPAC Name(8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum
SMILESCC(C)([NH-])C(=O)N[C@H](COCc1ccccc1)C(=O)O.CN1C(=O)N2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)[NH-])C[C@@]2(Cc2ccccn2)C1=O.O=C1N(CC(F)(F)F)C(=O)[C@]2(Cc3ccccn3)CNCCN12.[Pt].[Pt]
InChIInChI=1S/C27H33N6O5.C14H15F3N4O2.C14H19N2O4.2Pt/c1-26(2,28)23(35)30-21(17-38-16-19-9-5-4-6-10-19)22(34)32-13-14-33-25(37)31(3)24(36)27(33,18-32)15-20-11-7-8-12-29-20;15-14(16,17)9-20-11(22)13(7-10-3-1-2-4-19-10)8-18-5-6-21(13)12(20)23;1-14(2,15)13(19)16-11(12(17)18)9-20-8-10-6-4-3-5-7-10;;/h4-12,21,28H,13-18H2,1-3H3,(H,30,35);1-4,18H,5-9H2;3-7,11,15H,8-9H2,1-2H3,(H,16,19)(H,17,18);;/q-1;;-1;;/t21-,27+;13-;11-;;/m101../s1
InChIKeyPWKOLNXFTPHUJK-UNJYUEBCSA-N
XLogP4.02
TPSA300.92 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds19
Heavy Atoms83
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001519.36
LogP ≤ 54.02
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum?
The IUPAC name of (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum (CID 159049736) is (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum.
What is the SMILES notation for (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum?
The canonical SMILES for (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum is CC(C)([NH-])C(=O)N[C@H](COCc1ccccc1)C(=O)O.CN1C(=O)N2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)[NH-])C[C@@]2(Cc2ccccn2)C1=O.O=C1N(CC(F)(F)F)C(=O)[C@]2(Cc3ccccn3)CNCCN12.[Pt].[Pt].
What is the InChIKey of (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum?
The InChIKey is PWKOLNXFTPHUJK-UNJYUEBCSA-N. The full InChI is InChI=1S/C27H33N6O5.C14H15F3N4O2.C14H19N2O4.2Pt/c1-26(2,28)23(35)30-21(17-38-16-19-9-5-4-6-10-19)22(34)32-13-14-33-25(37)31(3)24(36)27(33,18-32)15-20-11-7-8-12-29-20;15-14(16,17)9-20-11(22)13(7-10-3-1-2-4-19-10)8-18-5-6-21(13)12(20)23;1-14(2,15)13(19)16-11(12(17)18)9-20-8-10-6-4-3-5-7-10;;/h4-12,21,28H,13-18H2,1-3H3,(H,30,35);1-4,18H,5-9H2;3-7,11,15H,8-9H2,1-2H3,(H,16,19)(H,17,18);;/q-1;;-1;;/t21-,27+;13-;11-;;/m101../s1.
What are the key properties of (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum?
(8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum has a molecular weight of 1519.36 g/mol, XLogP of 4.02, 19 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (8aS)-8a-(pyridin-2-ylmethyl)-2-(2,2,2-trifluoroethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1,3-dione;[1-[[(2R)-1-[(8aS)-2-methyl-1,3-dioxo-8a-(pyridin-2-ylmethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-1-oxo-3-phenylmethoxypropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]azanide;[1-[[(1R)-1-carboxy-2-phenylmethoxyethyl]amino]-2-methyl-1-oxopropan-2-yl]azanide;platinum is sourced from PubChem (CID 159049736), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).